Semax – Neuroactive Peptide for Research

Semax is a synthetic heptapeptide derived from a fragment of
adrenocorticotropic hormone (ACTH).
It was developed for research into cognitive performance, neuroprotection, and central nervous system signaling.
Unlike full-length ACTH, Semax does not exhibit hormonal activity, making it a focused compound for neurological studies.

This vial contains 10mg of high-purity Semax, produced under strict laboratory standards for in vitro research use.

Research Applications

• Cognitive function and memory research
• Neuroprotection and brain plasticity studies
• Stress-response and CNS signaling models
• Ischemia and hypoxia research
• Learning, focus, and attention pathway analysis

Scientific Background

Semax has been shown in research models to influence the expression of
brain-derived neurotrophic factor (BDNF)
and modulate neurotransmitter systems such as dopamine and serotonin.
These mechanisms have made Semax a compound of interest for studies involving learning, memory consolidation, and neuronal resilience.

Its peptide structure allows for stability and activity within experimental neurological environments, making it widely used in cognitive and neurobiology research.

Chemical Profile

Type: Synthetic heptapeptide
Origin: ACTH (4–10) analog
Form: Lyophilized powder
Purity: ≥98% (HPLC)

Manufactured in a controlled laboratory environment for research purposes only.

Storage & Handling

Store at −20°C, protected from light and moisture. After reconstitution, refrigerate at 2–8°C and avoid repeated freeze–thaw cycles.

For Research Use Only

Semax 10mg is intended strictly for in vitro laboratory research and is not for human or veterinary use.

• Semax – Wikipedia
• ACTH – Wikipedia
• BDNF – Wikipedia